Lidocaine

BreastfeedingPediatric
  • TRADE NAMES: Anamantle HC (Doak); Anestacon; Dentipatch; DermaFlex; Dilocaine; ELA-Max (Ferndale); EMLA (AstraZeneca); Lidodan; Lidoderm (Endo); Lidoject-2; Octocaine; Xylocaine (AstraZeneca); Xylocard
  • INDICATIONS: Ventricular arrhythmias, topical anesthesia
  • SYNONYM: lignocaine; xylocaine
  • CLASS: Anesthetic, local, Antiarrhythmic, Antiarrhythmic class Ib
  • HALF-LIFE: terminal: 1.5–2 hours

Our database has 64 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
RESPIRATORY
HEMATOLOGIC
OTIC
OCULAR
LOCAL
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric